Download Leukaemia Section t(1;21)(p32;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Gene expression profiling wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Copy-number variation wikipedia , lookup

Genome (book) wikipedia , lookup

Gene wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Short interspersed nuclear elements (SINEs) wikipedia , lookup

Medical genetics wikipedia , lookup

X-inactivation wikipedia , lookup

Microevolution wikipedia , lookup

RNA-Seq wikipedia , lookup

Epigenetics of human development wikipedia , lookup

Molecular Inversion Probe wikipedia , lookup

Designer baby wikipedia , lookup

Neocentromere wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Leukaemia Section
Mini Review
t(1;21)(p32;q22)
Charles D Bangs
Cytogenetics Laboratory, Rm. H1517, Stanford Hospital and Clinics, 300 Pasteur Dr. Stanford, CA 94305,
USA (CDB)
Published in Atlas Database: June 2003
Online updated version: http://AtlasGeneticsOncology.org/Anomalies/t0121p32q22ID1259.html
DOI: 10.4267/2042/37990
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2003 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Clinics and pathology
Cytogenetics
Disease
Cytogenetics morphological
Acute myelomonoblastic leukemia (M4 by FAB
subtype).
Single case
der(1)t(1;21).
Phenotype/cell stem origin
Cytogenetics molecular
CD34+, DR+, CD117+, CD15+, CD13+, CD33+,
MPO+, CD64+ blast population consistent with ANLLM4 by FAB subtype.
AML1 fusion suggested by partial translocation of 500
kb probe signal to der(1)t(1;21).
presented
with
second
copy
of
Probes
Etiology
Commercially available 500 kb AML1 probe.
Unknown, reported agricultural chemical exposure in
single case.
Genes involved and proteins
Epidemiology
Note
The putative 1p32 gene partner is unknown. Cryptic
t(12;21) TEL(ETV6)/AML1 rearrangement is unlikely
due to normal TEL metaphase FISH signal using
commercial TEL/AML1 probe.
Single case involving 25 year old male.
Clinics
Patient presented w/o palpable adenopathy, gingival
hyperplasia, systolic murmur, hepatosplenomegaly and
petechia. WBC was normal with anemia and
thrombocytopenia.
AML1
Location
21q22
DNA/RNA
AML1 is oriented 3' toward the centromere.
Protein
Contains a runt domain and at C-term a tranactivation
domain; forms heterodimers, widely expressed; nuclear
localization; transcription factor (activator) for various
hematopoietic-specific genes.
Cytology
Predominately large blasts with moderate cytoplasm,
smooth nuclear chromatin, and pro-minent nucleoli,
folded nuclear contours present in blast subset.
Treatment
Patient lost to treatment.
Evolution
Unknown.
Prognosis
Unknown.
Atlas Genet Cytogenet Oncol Haematol. 2003; 7(3)
183
t(1;21)(p32;q22)
Bangs CD
Chromosome and FISH images showing :
1) partial karyotype and ideogram of t(1;21)(p32;q22) including a second copy of the der(1)t(1;21) present in the clone; and
2) metaphase FISH showing red AML1 signal on the two copies of the der(t)t(1;21), the der(21)t(1;21) and the normal 21 homolog. Green
TEL signal is present of both 12 homologs indicating that no cryptic TEL/AML1 gene rearrangement is present. The adjacent interphase
nucleus shows four AML1 signals and two TEL signals consistent with the metaphase pattern.
To be noted
References
Case Report
t(1;21)(p32;q22) as a non-random abnormality in AML
M4
Cherry AM, Bangs CD, Jones P, Hall S, Natkunam Y. A unique
AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a
patient with acute myelomonocytic leukemia. Cancer Genet
Cytogenet. 2001 Sep;129(2):155-60
This article should be referenced as such:
Bangs CD. t(1;21)(p32;q22). Atlas Genet Cytogenet Oncol
Haematol. 2003; 7(3):183-184.
Atlas Genet Cytogenet Oncol Haematol. 2003; 7(3)
184